How much does Zepbound cost without insurance?

The number Eli Lilly publishes Eli Lilly's own pricing page states the list price of Zepbound is "$499 - $1,086.37 per fill" for a one-month supply. The $499 figure applies to single-dose vials purchased through LillyDirect self-pay; the $1,086.37 figure applies to the KwikPen at retail list price.

The public record on Zepbound pricing On August 27, 2024, Sen. Bernie Sanders, Chair of the Senate HELP Committee, issued an official Senate.gov statement noting that Eli Lilly had lowered the list price of the Zepbound starter dose "from over $1,000 a month to $399 a month, and the second dose to $549 a month" — while warning that Lilly simultaneously raised the price patients pay through the assistance program from $550 to $650. In the same statement, Sanders noted that Lilly's related diabetes drug Mounjaro (same molecule — tirzepatide) still costs $1,069 a month in the U.S. versus $485 in the United Kingdom and $94 in Japan.

What "without insurance" actually looks like at the pharmacy counter Cash-pay patients rarely see a single sticker price. Depending on the channel, they may pay: the LillyDirect self-pay vial price ($499 for the starter dose), the KwikPen list price (up to $1,086.37), a discounted pharmacy price with a coupon, or a manufacturer savings-card price if they qualify under Lilly's terms (which generally require commercial insurance). Exact out-of-pocket costs vary widely by pharmacy, dose, program, and eligibility, and can change over time.

Why the numbers can change List prices are set by the manufacturer and can be adjusted more than once a year — Lilly's August 2024 starter-dose cut is one such example. Real-world pharmacy prices also depend on dispensing fees, negotiated discounts, and whether a coupon, savings card, or LillyDirect self-pay option is in play. Any specific dollar figure is a snapshot — worth re-checking near the time you plan to fill a prescription.